logologo
QuantliQuantli

CAMP4 Therapeutics Corp

CAMP

NASDAQ

Biotechnology

$5.44

USD

+0.94 (+20.89%)

At close: Aug 14, 2026, 4:00 PM EDT

Market Cap $219.13M

Volume 408.3K

Price Target

$6.50$9.00

USD

The 2 analysts offering 1-year price forecasts have a max estimate of $9.00 and a min estimate of $6.50.

Price (USD)
Price (USD)

Past 2Y

1Y Forecast

Price Targets

Average Target

$7.75

-$0.3 vs prior

Implied Upside

+42.5%

-4.6% vs prior

Analyst Covering

2

Unchanged vs prior period

Consensus

Buy

Unchanged vs prior

Signal Quality

Consensus Freshness

50%

A mix of recent and older ratings shape this consensus

Analyst Agreement

Low

Targets are widely dispersed - limited agreement on price

Mean vs Median

$0 Gap

Median and average are closely aligned - few outliers skewing the consensus

Analyst Consensus

Strong Sell

Hold

Strong Buy

Buy

2 Buy

0 Hold

0 Sell

Rating Breakdown

Strong Buy

0

Buy

2

Hold

0

Sell

0

Strong Sell

0

2 analysts · last 3 months

Covering Analysts

Unlock each analyst's profile, success rate + price targets

Free shows the consensus and each analyst's current rating.

AnalystFirmRatingActionDateSuccess RatePrice TargetImplied Upside

Anupam Rama

JP Morgan

Buy

Upgraded

2 months ago

Plus
Plus
Plus

Keay Nakae

Chardan Capital

Buy

Initiated

2 months ago

Plus
Plus
Plus

Frequently Asked Questions

Similar Stocks

TLSI

TriSalus Life Sciences Inc

$5.27

-6.4%

SION

Sionna Therapeutics Inc

$6.46

-1.2%

AGEN

Agenus Inc

$7.32

+4.6%

AVXL

Anavex Life Sciences Corp

$3.22

-1.5%

FATE

Fate Therapeutics Inc

$2.57

+2.0%

IRD

Opus Genetics Inc

$3.61

-3.0%

SC

SCTX

Scribe Therapeutics Inc

$20.73

+1.8%

VNDA

Vanda Pharmaceuticals Inc

$5.22

+3.8%

IMRX

Immuneering Corp

$5.06

-2.7%